Working to Eradicate Gynecologic Cancers

Ellen Goode, PhD

Professor
Mayo Clinic
Mayo Clinic
200 First St SW
Rochester, MN
USA 55905

Papers:
60 KRAS variant rs61764370 is not associated with ovarian cancer risk or survival in the Ovarian Cancer Association Consortium (OCAC) or Consortium of Modifiers of BRCA1 and BRCA2 (CIMBA)